object
investig
viral
infect
patient
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
shanghai
analyz
clinic
characterist
biomark
viral
infect
method
studi
includ
consecut
patient
admit
diagnosi
aecopd
june
may
thirtyon
stabl
copd
patient
healthi
control
also
recruit
oropharyng
sampl
assess
pcr
respiratori
virus
perform
patient
divid
aecopd
virusposit
group
aecopd
virusneg
group
accord
viral
detect
luminex
use
detect
concentr
inflammatori
cytokin
serum
result
total
patient
includ
mean
age
year
patient
identifi
viral
posit
two
patient
detect
doubl
viral
infect
flua
flub
rsva
hrv
respect
rate
viral
detect
associ
season
highest
winter
comparison
clinic
characterist
show
signific
differ
aecopd
group
aecopd
group
howev
serum
concentr
interferoninduc
interferongamma
ifng
aecopd
patient
significantli
higher
aecopd
stabl
copd
healthi
control
group
p
conclus
viral
infect
import
pathogen
aecopd
patient
common
virus
includ
flua
hrv
flub
difficult
diagnos
viral
infect
accord
clinic
characterist
increas
serum
ifng
level
might
valu
indic
viral
infect
aecopd
acut
exacerb
chronic
obstruct
pulmonari
diseas
chronic
obstruct
pulmonari
diseas
cytokin
viral
infect
wileyonlinelibrarycomjournalcrj
clin
respir
j
chronic
obstruct
pulmonari
diseas
copd
common
respiratori
inflammatori
diseas
character
limit
incomplet
revers
airflow
tipe
yin
zhaoqin
zhu
contribut
studi
among
preval
chronic
diseas
throughout
world
estim
reach
next
two
decad
acut
exacerb
copd
consid
main
caus
mortal
especi
patient
sever
acut
exacerb
main
caus
acut
exacerb
copd
aecopd
includ
air
pollut
bacteri
infect
viral
infect
aecopd
correl
bacteri
viral
infect
viru
account
incid
viral
infect
lead
caus
copd
rhinoviru
hrv
account
approxim
pathogen
respiratori
syncyti
viru
rsv
human
coronaviru
hcov
influenza
viru
flu
parainfluenza
viru
piv
human
adenoviru
hadv
also
includ
caus
copd
bacteria
easili
separ
specif
remedi
effect
therefor
easier
confirm
virus
hard
isol
detect
bring
effect
treatment
outcom
therefor
import
viru
adequ
recogn
recent
develop
clinic
applic
nucleic
acid
detect
technolog
respiratori
virus
import
viral
infect
aecopd
increasingli
regard
clinician
expect
find
highli
specif
biomark
easili
quickli
confirm
viral
infect
aecopd
level
creaction
protein
crp
increas
rapidli
seriou
infect
suggest
crp
procalcitonin
pct
may
provid
valuabl
evid
distinguish
bacteri
viral
infect
also
report
aecopd
correl
higher
level
airway
proinflammatori
cytokin
viral
infect
moreov
found
increas
interferoninduc
associ
hrv
infect
therefor
consid
biomark
hrv
infect
addit
report
till
date
regard
biomark
aecopd
associ
viral
origin
studi
recent
year
show
pathogen
involv
respiratori
viral
infect
shanghai
mainli
flu
hrv
patient
includ
adult
children
acut
respiratori
tract
infect
studi
shanghai
result
show
main
pathogen
flu
hrv
xia
et
al
investig
adult
patient
acut
respiratori
tract
infect
shanghai
indic
respiratori
tract
infect
mainli
caus
flua
follow
flub
two
studi
focus
preval
pathogen
involv
respiratori
tract
infect
shanghai
henc
order
elucid
broad
spectrum
viral
infect
aecopd
patient
determin
biomark
associ
clinic
featur
viral
infect
studi
prospect
investig
viral
pathogen
aecopd
patient
hospit
hospit
level
serum
cytokin
ifng
interleukin
il
tumor
necrosi
factor
tnf
determin
among
aecopd
virusposit
aecopd
virusneg
stabl
copd
healthi
control
group
hope
find
specif
biomark
relat
viral
infect
aecopd
june
may
cliniciandiagnos
aecopd
patient
male
femal
mean
age
year
old
consecut
admit
enrol
studi
everi
quarter
swab
sampl
collect
aecopd
patient
averag
meanwhil
patient
elig
stabl
copd
criteria
well
healthi
control
select
screen
popul
jiangchuan
commun
minhang
district
shanghai
april
juli
studi
approv
ethic
committe
fifth
peopl
hospit
shanghai
fudan
univers
particip
sign
written
inform
consent
form
copd
diagnos
accord
gold
criteria
postbronchodil
forc
expiratori
volum
second
forc
vital
capac
fvc
ratio
aecopd
defin
acut
event
character
worsen
respiratori
symptom
dyspnea
sputum
purul
sputum
volum
beyond
normal
daytoday
variat
led
chang
medic
stabl
copd
defin
without
symptom
exacerb
chang
treatment
within
last
week
patient
assign
copd
stage
base
gold
criteria
accord
recent
avail
spirometr
valu
last
month
aecopd
patient
perform
spirometri
symptom
bad
reliev
discharg
within
one
month
discharg
hospit
standard
pulmonari
function
test
perform
dri
spiromet
devic
quark
pft
ergo
cosm
itali
minut
inhal
salbutamol
lg
ventolin
glaxosmithklin
london
uk
fvc
ratio
record
exclus
criteria
aecopd
copd
includ
meet
inclus
criteria
complet
pulmonari
function
test
primari
diagnosi
asthma
bronchiectasi
lung
cancer
activ
chronic
respiratori
diseas
requir
treatment
intervent
diagnost
sever
uncontrol
comorbid
mental
disord
inclus
criteria
healthi
control
year
includ
absenc
infect
histori
respiratori
diseas
sever
uncontrol
diseas
abnorm
find
physic
examin
chest
xray
pulmonari
function
test
last
two
month
initi
studi
aecopd
group
serum
sampl
accident
destroy
storag
henc
exclud
would
result
sever
hemolysi
hyperlipidemia
sampl
show
great
impact
result
qiagen
nucleic
acid
extract
kit
purchas
roch
switzerland
takara
revers
transcript
polymeras
chain
reaction
rtpcr
detect
kit
purchas
takara
japan
kit
purchas
merck
millipor
germani
reagent
manufactur
purchas
china
primer
probe
provid
depart
pathogen
detect
biosecur
shanghai
public
health
clinic
center
affili
fudan
univers
support
inform
tabl
follow
paramet
record
admiss
age
sex
stage
copd
accord
gold
criteria
smoke
habit
comorbid
confirm
medic
record
durat
antibiot
usag
diseas
outcom
length
hospit
stay
patient
underw
routin
blood
examin
includ
creactiv
protein
blood
routin
liver
function
blood
coagul
function
blood
ga
analysi
swab
sampl
collect
patient
within
hour
admiss
transfer
test
tube
screw
cap
test
tube
carri
ml
minimum
essenti
medium
contain
mgml
gentamicin
uml
penicillin
lgml
amphotericin
b
fetal
bovin
serum
store
temporarili
refriger
transfer
lab
within
hour
patient
ml
blood
sampl
harvest
intraven
separ
serum
store
refriger
high
pure
viral
nucleic
acid
kit
roch
switzerland
use
extract
dnarna
swab
sampl
extract
dissolv
eluent
immedi
transfer
refriger
prepar
use
primer
probe
provid
depart
pathogen
detect
biosecur
shanghai
public
health
clinic
center
affili
fudan
univers
onestep
realtim
pcr
reaction
perform
realtim
fluoresc
quantit
pcr
nine
type
respiratori
virus
detect
includ
flua
flub
hadv
rsva
rsvb
hrv
piv
human
bocaviru
hbov
human
metapneumoviru
hmpv
reaction
system
takara
japan
consist
buffer
ex
taqh
enzym
mix
upstream
primer
downstream
primer
probe
h
rna
templat
use
reaction
condit
includ
revers
transcript
minut
predegener
minut
degener
second
cycl
anneal
extens
second
collect
fluoresc
anneal
temperatur
nine
type
respiratori
virus
determin
fam
fam
fam
fam
fam
hex
fam
fam
fluoresc
signal
respect
posit
judgment
principl
includ
ct
valu
amplif
curv
ct
valu
good
amplif
curv
directli
judg
posit
ct
valu
need
repeat
experi
two
test
get
good
amplif
curv
judg
posit
hcov
detect
use
rtpcr
reaction
system
consist
buffer
ex
taqh
enzym
mix
upstream
primer
downstream
primer
h
rna
templat
use
reaction
condit
includ
revers
transcript
minut
predegener
minut
cycl
degener
second
minut
cycl
anneal
extens
second
minut
pcr
product
electrophores
agaros
gel
type
viru
judg
refer
posit
qualiti
product
merck
millipor
human
cytokinechemokin
magnet
bead
panel
kit
plate
use
detect
serum
cytokin
ifng
tnfa
serum
ad
plate
accord
manufactur
instruct
result
analyz
store
median
fluoresc
intens
data
logist
spline
curv
fit
adopt
calcul
cytokin
concentr
sampl
discret
variabl
express
count
percentag
continu
variabl
express
mean
standard
deviat
median
interquartil
differ
test
use
compar
mean
independ
sampl
two
group
mannwhitney
test
use
analyz
median
independ
sampl
two
group
chisquar
v
test
fisher
exact
probabl
method
util
compar
discret
variabl
spearman
correl
test
adopt
assess
correl
independ
sampl
two
group
p
consid
statist
signific
spss
softwar
graphpad
use
statist
analysi
durat
june
may
divid
four
season
spring
summer
autumn
winter
found
viral
infect
appear
aecopd
patient
everi
season
winter
season
wit
infect
follow
spring
summer
common
viral
pathogen
flua
flub
hrv
specif
distribut
commonli
detect
virus
follow
aecopd
patient
divid
aecopd
group
n
aecopd
group
n
statist
signific
differ
observ
clinic
indic
age
sex
histori
smoke
complic
bodi
temperatur
blood
routin
liver
function
blood
coagul
function
durat
antibiot
use
diseas
outcom
length
hospit
stay
aecopd
group
aecopd
group
p
tabl
base
definit
older
elderli
person
world
health
organ
classifi
aecopd
tabl
addit
adopt
diagnost
criteria
communityacquir
pneumonia
also
classifi
patient
aecopd
group
patient
pneumonia
group
n
patient
without
pneumonia
group
n
compar
clinic
indic
two
group
found
patient
two
group
differ
significantli
bodi
temperatur
erythrocyt
sediment
rate
length
hospit
stay
day
antibiot
use
p
tabl
serum
sampl
collect
aecopd
patient
n
aecopd
patient
n
stabl
copd
patient
n
healthi
volunt
n
respect
consid
serum
sampl
aecopd
patient
avail
pool
far
aecopd
patient
keep
sampl
two
group
close
collect
year
select
serum
sampl
size
equal
aecopd
patient
neg
control
comparison
concentr
eight
cytokin
ifng
tnfa
among
four
group
indic
concentr
ifng
aecopd
group
significantli
increas
significantli
higher
aecopd
group
stabl
copd
group
healthi
control
group
p
p
ifng
signific
differ
observ
remain
cytokin
p
tabl
moreov
also
assess
correl
concentr
fev
predict
valu
show
concentr
either
aecopd
group
aecopd
group
correl
fev
predict
valu
p
figur
b
current
copd
becom
grow
epidem
throughout
world
upper
respiratori
tract
viru
infect
lead
sever
acut
exacerb
copd
rel
longer
recoveri
time
exacerb
associ
increas
airway
inflamm
therefor
extrem
import
detect
respiratori
virus
screen
biomark
aecopd
patient
viral
infect
studi
posit
viral
detect
rate
aecopd
patient
shanghai
obvious
lower
studi
result
dai
et
al
de
et
al
dimopoulo
et
al
biancardi
et
al
rohd
et
al
obvious
higher
studi
result
ko
et
al
chang
et
al
koul
et
al
variat
might
associ
comprehens
factor
geographi
season
preval
pathogen
econom
statu
region
influenc
vaccin
major
infect
caus
virus
flua
hrv
flub
studi
flu
flua
flub
highli
detect
viru
result
consist
studi
result
koul
et
al
tan
et
al
biancardi
et
al
inconsist
studi
result
hosseini
et
al
dimopoulo
et
al
kherad
et
al
greenberg
et
al
characterist
flu
frequent
occur
temper
zone
especi
east
asia
might
anoth
reason
preval
viru
infect
china
hrv
preval
follow
flu
inconsist
studi
result
wilkinson
et
al
djamin
et
al
euroamerican
region
euroamerican
region
hrv
primari
infect
viru
patient
aecopd
hrv
lack
effect
vaccin
henc
higher
euroamerican
region
asian
region
virus
hadv
rsva
hcov
detect
low
rate
respect
inconsist
studi
result
exampl
hosseini
et
al
note
p
consid
statist
signific
data
present
number
mean
sd
test
chisquar
test
adopt
abbrevi
aecopd
acut
exacerb
chronic
obstruct
neut
neutrophil
count
ly
lymphocyt
count
eo
eosinophil
count
hgb
hemoglobin
concentr
esr
erythrocyt
sediment
rate
crp
creactiv
protein
pct
procalcitonin
alt
alanin
aminotransferas
ldh
lactat
dehydrogenas
ck
creatin
kinas
pap
pulmonari
arteri
pressur
gold
global
initi
chronic
obstruct
lung
diseas
fev
forc
expiratori
volum
one
second
fvc
forc
vital
capac
show
hmpv
second
common
viru
detect
two
respiratori
virus
discov
recent
dilemma
still
exist
whether
relat
copd
exacerb
differ
detect
rate
research
still
warrant
definit
conclus
dual
viral
infect
rate
low
studi
mainli
combin
flua
flub
rsva
hrv
hosseini
et
al
mcmanu
et
al
malekshahi
et
al
found
dual
viral
infect
rate
high
mainli
combin
rsv
hadv
hrv
enteroviru
ev
studi
flua
flub
observ
new
uncommon
viral
coinfect
may
turn
lead
cocircul
copd
crowd
also
found
frequenc
viral
infect
remain
highest
winter
season
consist
studi
result
zwaan
et
al
dimopoulo
et
al
season
distribut
influenza
viru
patient
aecopd
compar
adult
time
shanghai
clinic
manifest
aecopd
patient
lack
specif
studi
consist
studi
result
chang
et
al
dimopoulo
et
al
found
length
hospit
stay
aecopd
patient
significantli
higher
aecopd
indic
might
difficult
differenti
viral
infect
nonvir
infect
base
sole
clinic
data
addit
studi
also
found
older
patient
significantli
higher
nonelderli
patient
viral
infect
accord
studi
result
dimopoulo
et
al
might
associ
region
differ
poor
physic
state
long
copd
cours
suscept
secondari
bacteri
infect
long
recoveri
durat
studi
also
found
respiratori
virus
show
signific
increas
serum
ifng
level
consist
studi
result
almansa
et
al
slight
differ
observ
quint
et
al
studi
quint
et
al
found
effect
biomark
hrvrelat
aecopd
aecopd
group
studi
contain
seven
type
respiratori
virus
addit
hrv
whether
seven
type
respiratori
virus
affect
signific
increas
concentr
worth
investig
result
show
obviou
differ
ifng
result
almansa
et
al
studi
studi
also
demonstr
respiratori
virus
caus
signific
rise
ifng
level
might
associ
differ
sampl
size
therefor
two
biomark
might
provid
certain
refer
valu
indic
viral
infect
studi
limit
first
high
sensit
quantit
pcr
techniqu
respiratori
virus
also
found
patient
stabl
copd
although
rule
viru
particl
remain
respiratori
tract
previou
exacerb
patient
still
stabl
diseas
condit
might
subject
futur
longitudin
studi
second
studi
includ
sputum
cultur
common
bacteria
complet
separ
viru
bacteria
thu
sampl
mix
viralbacteri
coinfect
turn
might
influenc
comparison
clinic
data
serum
biomark
conclus
nucleic
acid
detect
respiratori
virus
show
higher
viral
detect
rate
aecopd
patient
shanghai
provinc
china
hong
kong
taiwan
common
virus
includ
flua
hrv
flub
aecopd
patient
posit
viru
lack
typic
clinic
characterist
increas
serum
ifng
level
might
act
potenti
valuabl
biomark
diagnosi
aecopd
find
improv
awar
regard
import
viral
infect
aecopd
